Completed
Phase 2
Age: 19Years - 57Years
All Genders
ID00000353
EfficacySafety Trial of BuprenorphineNx for Opiate Dependence
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-18
N/A
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
CONDITIONS
Brief Title
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here